• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form NT 10-K filed by American Shared Hospital Services

    3/31/25 2:53:13 PM ET
    $AMS
    Medical Specialities
    Health Care
    Get the next $AMS alert in real time by email
    NT 10-K 1 asha20250329_nt10k.htm FORM NT 10-K asha20250329_nt10k.htm

     



     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     


     

    FORM 12b-25

     


     

    NOTIFICATION OF LATE FILING

    Commission File Number: 001-40793

    (Check One): ☒Form 10-K ☐ Form 20-F ☐ Form 11-K  
      ☐Form 10-Q ☐ Form 10-D ☐ Form N-SAR  ☐ Form N-CSR

     

      For Period Ended: December 31, 2024

     

     

    ☐

    Transition Report on Form 10-K

     

    ☐

    Transition Report on Form 20-F

     

    ☐

    Transition Report on Form 11-K

     

    ☐

    Transition Report on Form 10-Q

     

    ☐

    Transition Report on Form N-SAR

         
     

    For the Transition Period Ended: _______________

     

    Nothing in this Form shall be construed to imply that the Commission has verified any information contained herein.

     

    If the notification relates to a portion of the filing checked above, identify the item(s) to which the notification relates:

     

     

     

     

    PART I — REGISTRANT INFORMATION

     

    American Shared Hospital Services

    (Full Name of Registrant)

     

    Not applicable


    (Former Name if Applicable)

     

    601 Montgomery Street, Suite 850

    (Address of Principal Executive Office (Street and Number))

     

    San Francisco, California 94111-2619

    (City, State and Zip Code)

     



     

     

     

     

    PART II — RULES 12b-25(b) AND (c)

     

    If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate.)

     

     

    (a)

    The reasons described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense;

    ☒

    (b)

    The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K, Form N-SAR or Form N-CSR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q or subject distribution report on Form 10-D, or portion thereof, will be filed on or before the fifth calendar day following the prescribed due date; and

     

    (c)

    The accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.

     

     

     

     

    PART III— NARRATIVE

     

    State below in reasonable detail why Forms 10-K, 20-F, 11-K, 10-Q, 10-D, N-CEN, N-CSR or the transition report portion thereof, could not be filed within the prescribed time period.

     

    American Shared Hospital Services (the “Company”) is filing this Notification of Late Filing on Form 12b-25 with respect to its Annual Report on Form 10-K for the year ended December 31, 2024 (the “Annual Report”). For the reasons and circumstances set forth below, the Company has determined that it is unable to file its Annual Report within the prescribed time period without unreasonable effort or expense.

     

    On May 7, 2024, the Company completed its acquisition of 60% of the equity interests of Southern New England Regional Cancer Center, LLC and Roger Williams Radiation Therapy, LLC (the “RI Entities”) out of bankruptcy (such acquisition, the “RI Acquisition”). Due to the lack of reliable financial information for the RI Entities following the protracted bankruptcy proceedings, the Company’s analysis and integration of balance sheet line items as of December 31, 2024 and the impact on fiscal year 2024 revenues and expenses associated with the RI Acquisition, has required more time and resources than anticipated. As a result, the Company determined that it needs additional time to complete certain accounting processes related to the RI Acquisition in order to finalize its Annual Report.

     

    Additionally, as previously reported by the Company in a Current Report on Form 8-K filed with the SEC on December 26, 2024, on December 19, 2024, the Company appointed a new Chief Financial Officer who also serves as the Company’s principal financial officer and principal accounting officer. In connection with this transition, the new Chief Financial Officer requires additional time to review the accuracy and completeness of the Company’s financial statements and related disclosures to ensure their accuracy and completeness before certifying the Annual Report.

     

    The above constraints have inhibited the Company’s ability to timely complete the Annual Report.

     

    The Company is working diligently to complete the Annual Report as soon as possible and anticipates that it will file the Annual Report within the extension period granted under Rule 12b-25 of the Securities Exchange Act of 1934, as amended.

     

     

     

     

    PART IV — OTHER INFORMATION

     

    (1)

    Name and telephone number of person to contact in regard to this notification

     

     

    Raymond C. Stachowiak

     

    (415)

     

    788-5300

     

    (Name)

     

    (Area Code)

     

    (Telephone Number)

     

    (2)

    Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If the answer is no, identify report(s).

     

    ☐ Yes ☒ No

     

      The Company has not filed a Current Report on Form 8-K (Item 9.01) containing financial information related to its acquisition of the RI Entities in accordance with Rules 8-04 and 8-05 of Regulation S-X.
       

    (3)

    Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof?

     

    ☒ Yes ☐ No

     

    If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.

     

    The Company expects to report a significant increase in net income for fiscal 2024 compared to fiscal 2023, with that increase being primarily as a result of increased revenues during 2024 attributable, in part, to its increased direct patient service revenue resulting from the RI Acquisition that closed during 2024 and a bargain purchase gain recognized from the RI Acquisition, but, partially offset by increased costs of revenues during the 2024 fiscal year and a loss on write down on impaired assets. 

     

     

     

     

    Disclosure Regarding Forward-Looking Statements

     

    This Notification of Late Filing on Form 12b-25 may be deemed to contain certain “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The Private Securities Litigation Reform Act of 1995 has established that these statements qualify for safe harbors from liability. Forward‑looking statements may include words like “believe”, “anticipate”, “target”, “expect”, “pro forma”, “estimate”, “intend”, “will”, “is designed to”, “plan” and words of similar meaning. Forward‑looking statements describe our future plans, objectives, expectations or goals. Such statements address future events and conditions and include, but are not limited to, statements regarding our beliefs and expectations regarding the timing of the completion of the Company’s financial statements and the filing of the Annual Report, all of which reflect the Company’s expectations based upon currently available information and data. Because such statements are based on the Company’s current expectations and are not statements of fact, actual results may differ materially from those projected or estimated, and you are cautioned not to place undue reliance on these forward‑looking statements. These forward-looking statements are not guarantees of future performance, conditions, or results, and involve a number of known and unknown risks, uncertainties, assumptions, and other important factors, many of which are outside the Company’s control, that could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements. Further information on potential factors that could affect the Company’s financial condition, results of operations, and future plans is included in the filings that the Company has made with the SEC, including the Company’s Annual Report on Form 10-K for the year ended December 31, 2023 and the Company’s Quarterly Reports on Form 10-Q for the periods ended March 31, 2024, June 30, 2024 and September 30, 2024. Such filings and other documents filed by the Company with the SEC are and will be available at www.sec.gov. Any forward‑looking statement speaks only as of the date such statement was made, and we are not obligated to update any forward‑looking statement to reflect events or circumstances after the date on which such statement was made, except as required by applicable laws or regulations.

     

     

     

     

    American Shared Hospital Services

    (Name of Registrant as Specified in Charter)

     

    Has caused this notification to be signed on its behalf by the undersigned thereunto duly authorized.

     

    Date: March 31, 2025

    By:

    /s/ Raymond C. Stachowiak

     

    Name: 

    Raymond C. Stachowiak

     

    Title:

    Executive Chairman of the Board and Chief Executive Officer

       

    (Principal Executive Officer)

     

     

     
    Get the next $AMS alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $AMS

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $AMS
    SEC Filings

    See more
    • SEC Form DEFA14A filed by American Shared Hospital Services

      DEFA14A - AMERICAN SHARED HOSPITAL SERVICES (0000744825) (Filer)

      4/30/25 3:24:24 PM ET
      $AMS
      Medical Specialities
      Health Care
    • SEC Form DEF 14A filed by American Shared Hospital Services

      DEF 14A - AMERICAN SHARED HOSPITAL SERVICES (0000744825) (Filer)

      4/30/25 3:15:03 PM ET
      $AMS
      Medical Specialities
      Health Care
    • SEC Form 10-K filed by American Shared Hospital Services

      10-K - AMERICAN SHARED HOSPITAL SERVICES (0000744825) (Filer)

      4/4/25 5:19:54 PM ET
      $AMS
      Medical Specialities
      Health Care

    $AMS
    Financials

    Live finance-specific insights

    See more
    • American Shared Hospital Services Reports Fourth Quarter and Strong Full Year 2024 Financial Results

      Appoints Gary Delanois as Chief Executive Officer Conference Call Scheduled for 1:00 PM ET Today SAN FRANCISCO, April 04, 2025 (GLOBE NEWSWIRE) -- American Shared Hospital Services (NYSE:AMS) (the "Company"), a leading provider of stereotactic radiosurgery equipment and advanced radiation therapy cancer treatment services through its leasing or direct patient care services segments, today announced financial results for the fourth quarter and full year ended December 31, 2024. Key Financial Highlights FY 2024 Revenue Increased 32.9% Year over Year Driven by Strategic Expansion and Operational StrengthFY 2024 Direct Patient Services Revenue Increased 253.4% Year over YearNet Income Attr

      4/4/25 7:00:00 AM ET
      $AMS
      Medical Specialities
      Health Care
    • American Shared Hospital Services Announces Fourth Quarter and Full Year 2024 Earnings Conference Call

      SAN FRANCISCO, March 31, 2025 (GLOBE NEWSWIRE) -- American Shared Hospital Services (NYSE:AMS) (the "Company"), a leading provider of stereotactic radiosurgery and advanced radiation therapy cancer treatment services, today announced that the Company will hold a conference call to discuss its fourth quarter and full year 2024 financial results on April 4th at 1:00 pm ET. The fourth quarter and full-year 2024 financial results press release will be issued before the market opens on April 4th. Teleconference and Webcast Information To participate, domestic callers may dial 1-844-413-3972 and international callers may dial 1-412-317-5776 at least 10 minutes prior to the start of the call a

      3/31/25 4:01:00 PM ET
      $AMS
      Medical Specialities
      Health Care
    • American Shared Hospital Services Reports Third Quarter 2024 Financial Results

      - Revenue increases 36.3% period over period - Conference Call on November 13th at 1:00 pm ET SAN FRANCISCO, Nov. 13, 2024 (GLOBE NEWSWIRE) -- American Shared Hospital Services (NYSE:AMS) (the "Company"), a leading provider of turnkey technology solutions for stereotactic radiosurgery and advanced radiation therapy cancer treatment systems and services, today announced financial results for the third quarter ended September 30, 2024. Third Quarter 2024 and Recent Highlights Total revenue in the third quarter was $6,999,000, an increase of 36.3% from the comparable period in 2023 bolstered by the completion of our acquisition in May 2024 (the "RI Acquisition") of 60% of the equity inte

      11/13/24 7:00:00 AM ET
      $AMS
      Medical Specialities
      Health Care

    $AMS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13D filed by American Shared Hospital Services

      SC 13D - AMERICAN SHARED HOSPITAL SERVICES (0000744825) (Subject)

      11/20/24 4:59:03 PM ET
      $AMS
      Medical Specialities
      Health Care
    • SEC Form SC 13D/A filed by American Shared Hospital Services (Amendment)

      SC 13D/A - AMERICAN SHARED HOSPITAL SERVICES (0000744825) (Subject)

      4/3/24 12:14:23 PM ET
      $AMS
      Medical Specialities
      Health Care
    • SEC Form SC 13D/A filed by American Shared Hospital Services (Amendment)

      SC 13D/A - AMERICAN SHARED HOSPITAL SERVICES (0000744825) (Subject)

      12/18/23 4:44:44 PM ET
      $AMS
      Medical Specialities
      Health Care

    $AMS
    Leadership Updates

    Live Leadership Updates

    See more
    • American Shared Hospital Services Announces Key Management Appointments

      Hires Gary Delanois, Seasoned Radiation Oncology Services Executive, as Chief Operating Officer Promotes Ranjit Pradhan to Senior Vice President of Sales and Marketing SAN FRANCISCO, Oct. 18, 2024 (GLOBE NEWSWIRE) -- American Shared Hospital Services (NYSE:AMS) (the "Company"), a leading provider of turnkey technology solutions for stereotactic radiosurgery and advanced radiation therapy cancer treatment systems and services, today announced the appointment of Gary Delanois as Executive Vice President and Chief Operating Officer. Mr. Delanois brings many years of industry expertise in the management of radiation oncology services. Additionally, the Company announced the promotion of Ranj

      10/18/24 2:58:45 PM ET
      $AMS
      Medical Specialities
      Health Care
    • American Shared Hospital Services Strengthens Senior Management Structure

      SAN FRANCISCO, April 18, 2024 (GLOBE NEWSWIRE) -- American Shared Hospital Services (NYSE:AMS) (the "Company"), a leading provider of turnkey technology solutions for stereotactic radiosurgery and advanced radiation therapy equipment and services, today announces changes to strengthen its senior management structure. AMS' current Executive Chairman, Ray Stachowiak, will take on the role of Executive Chairman and Chief Executive Officer, and the Company's President, Craig Tagawa, will become President and Chief Operating Officer, effective immediately. Bob Hiatt will continue to serve as the Company's Chief Financial Officer. Ernie Bates will continue in the role of Vice President of I

      4/18/24 8:00:00 AM ET
      $AMS
      Medical Specialities
      Health Care
    • American Shared Hospital Services Strengthens Management Team with Appointment of Peter Gaccione as Chief Operating Officer

      Gaccione is a Well Known & Respected Radiation Oncology Business Development, Sales & Management Executive SAN FRANCISCO, CA, Sept. 01, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – American Shared Hospital Services (NYSE:AMS) (the "Company"), a leading provider of turnkey technology solutions for stereotactic radiosurgery and advanced radiation therapy equipment, facilities, and services, today announced the appointment of Peter Gaccione as Chief Operating Officer (COO), effective September 7th, 2022. Mr. Gaccione assumes the COO position from Craig Tagawa who remains the Company's President and Chief Financial Officer. Mr. Gaccione has over 40 years of experience and leadership in the gl

      9/1/22 4:05:00 PM ET
      $AMS
      Medical Specialities
      Health Care

    $AMS
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • American Shared Hospital Services Announces Annual Shareholder Meeting to be Held on Thursday, June 26, 2025

      SAN FRANCISCO, April 11, 2025 (GLOBE NEWSWIRE) -- American Shared Hospital Services (NYSE:AMS) (the "Company"), a leading provider of stereotactic radiosurgery equipment and advanced radiation therapy cancer treatment services through its leasing or direct patient care services segments, today announced that its Annual Meeting of Shareholders will be held on Thursday, June 26, 2025, at 9:00 a.m. CT. The Annual Meeting will be an in-person meeting. For those who wish to attend, the meeting will be held at 3041 Woodcreek Drive, #200, Downers Grove, IL 60515. The Board of Directors fixed the close of business on April 28, 2025, as the record date for determination of shareholders entitled to

      4/11/25 7:00:00 AM ET
      $AMS
      Medical Specialities
      Health Care
    • American Shared Hospital Services to Present at the Planet MicroCap Showcase: VEGAS in partnership with MicroCapClub

      SAN FRANCISCO, April 09, 2025 (GLOBE NEWSWIRE) -- American Shared Hospital Services (NYSE:AMS) (the "Company"), a leading provider of stereotactic radiosurgery equipment and advanced radiation therapy cancer treatment services through its leasing or direct patient care services segments, today announced that it will be presenting at the Planet MicroCap Showcase: VEGAS 2025 in partnership with MicroCapClub on Wednesday, April 23, 2025 at 12:00 PM ET. Ray Stachowiak, Executive Chairman, and Gary Delanois, Chief Executive Officer of American Shared Hospital Services, will host the presentation and answer questions at the conclusion. To access the live presentation, please use the following

      4/9/25 7:00:00 AM ET
      $AMS
      Medical Specialities
      Health Care
    • American Shared Hospital Services Reports Fourth Quarter and Strong Full Year 2024 Financial Results

      Appoints Gary Delanois as Chief Executive Officer Conference Call Scheduled for 1:00 PM ET Today SAN FRANCISCO, April 04, 2025 (GLOBE NEWSWIRE) -- American Shared Hospital Services (NYSE:AMS) (the "Company"), a leading provider of stereotactic radiosurgery equipment and advanced radiation therapy cancer treatment services through its leasing or direct patient care services segments, today announced financial results for the fourth quarter and full year ended December 31, 2024. Key Financial Highlights FY 2024 Revenue Increased 32.9% Year over Year Driven by Strategic Expansion and Operational StrengthFY 2024 Direct Patient Services Revenue Increased 253.4% Year over YearNet Income Attr

      4/4/25 7:00:00 AM ET
      $AMS
      Medical Specialities
      Health Care

    $AMS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • President Tagawa Craig Kenji was granted 5,613 shares, increasing direct ownership by 19% to 35,501 units (SEC Form 4)

      4 - AMERICAN SHARED HOSPITAL SERVICES (0000744825) (Issuer)

      5/2/25 11:49:55 AM ET
      $AMS
      Medical Specialities
      Health Care
    • Chief Financial Officer Frech Raymond Scott was granted 50,000 shares (SEC Form 4)

      4 - AMERICAN SHARED HOSPITAL SERVICES (0000744825) (Issuer)

      12/23/24 8:19:24 PM ET
      $AMS
      Medical Specialities
      Health Care
    • SEC Form 3 filed by new insider Frech Raymond Scott

      3 - AMERICAN SHARED HOSPITAL SERVICES (0000744825) (Issuer)

      12/23/24 8:18:51 PM ET
      $AMS
      Medical Specialities
      Health Care